Patient engagement
Medical care for patients with advanced disease should be aimed at symptom control, psychosocial support and spiritual needs. Patients' preferences regarding care and their wishes concerning their place of residence should be central in the decision making. Currently, treatment aimed at prolonging life has been found to often prevail over care aimed at relieving patients' suffering and enhancing their quality of life, which is not always in accordance with patients' needs and aims. 1 As a result, preferred care and care as received do not always align. Increased patient engagement in care is suggested as one of the most promising approaches to counter such lack of alignment. Patient engagement is the "partnership among patients, families, and professional caregivers that ensures that patients' needs and preferences are respected in medical decision making, and that supports them in directing their own care." 2 Studies have shown that many patients appreciate engagement in medical care and decision making. 3 Such engagement leads to better health outcomes and improvements in quality of care and patient safety. 4 Patient engagement also has the potential to reduce healthcare costs. 5 Moreover, it can be argued that patient engagement in healthcare is inevitable as health policy more and more moves towards participatory healthcare, partly driven by incentives to reduce costs.
Advance care planning
One model of care to improve patient engagement is advance care planning (ACP). ACP is a process where patients are supported in defining preferences for future medical treatment, in discussing these with relatives and physicians, and in recording these in an advance directive. 6 There is an increasing interest in ACP, indicated by a nearly two-fold number of publications on the topic in 2010-2015 compared to 2005-2010, an increased number of ACP interventions and guidelines incorporating ACP, and increased media attention to the topic. Initially, most ACP studies were performed among older nursing home patients with the main aim of establishing patients' preferences before they lose their competence. ACP is now expected to also be effective in improving the quality of life of competent patients with, for example, advanced cancer, because it can support them in timely recognizing and expressing their needs and preferences which will enable strategic and effective planning of care and decision making. The increased interest in ACP raises several issues and challenges.
Challenges in ACP
First of all, ACP should preferably be applied in an evidence-based way. To date, only a few randomized controlled studies have provided convincing evidence demonstrating the effectiveness of ACP. 6 Methodologically robust studies on ACP are complex. One methodological challenge, for instance, is the variance in models of ACP. While the completion of a written advance directive is considered to represent ACP in some studies, others use more comprehensive models in which ACP is understood to be a complex intervention that includes facilitated reflection and communication, the completion of documents, as well as fundamental changes in the provision and culture of healthcare. Hence, there is a need for a more unequivocal interpretation and definition of ACP to enable comparing different models. Another challenge concerns determining the most relevant outcome measure, not in the least because the preferred effect of a complex intervention like ACP may differ from patient to patient.
Second, as Murray et al. (2016) indicate in this issue, there is a need for guidance regarding the timing and style of introducing ACP to patients and their families. Choosing the right moment along a patient's trajectory of advancing disease and care and using appropriate wording for engaging patients in ACP may have a profound impact on the value and effects of ACP. Introducing ACP too early, at a stage where patients are not or not yet willing to consider possible future deterioration of their health, may lead to reluctance or elicitation of merely hypothetical preferences, while engaging in ACP in the face of a calamity shortly before dying is obviously too late. 7 Third, it can be questioned whether ACP is beneficial and appealing to everyone. While several studies reveal that many patients with advanced diseases prefer to maintain their autonomy and to be actively engaged in medical decision making, not all patients are willing and able to do so. This is illustrated by the qualitative study of Bollig et al. (2016) that is presented in this issue, showing that several Norwegian nursing home residents do not consider ACP to be important, and prefer to live "one day at a time." Advance care planning: Not a panacea 642963P MJ0010.1177/0269216316642963Palliative MedicineEditorial
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Editorial Palliative Medicine 30 (5) Such a preference not to be involved in ACP needs to be respected, provided the patient is properly informed about what ACP entails and has sufficient decision-relevant knowledge.
Fourth, ACP runs the risk to be regarded as a panacea for other complex issues in medical care for patients with serious advanced disease. We should be careful that the primary focus of ACP is to support the alignment of medical care and treatment with the patient's wishes and preferences. In this issue, Klinger et al. (2016) demonstrate in their review that ACP may in addition result in net medical cost savings, confirming previous findings. 8 In their ethical reflection, they convincingly argue that cost-effectiveness is a delicate topic because calculating the cost-effectiveness of ACP may be considered equal to aiming at cost-reduction by facilitating ACP. This was illustrated by the transfiguration in the popular press of a proposal to provide Medicare reimbursement to physicians for ACP into the creation of "death panels." Concerns about the focus of ACP can also be raised regarding a claim in Bollig's article where the authors state that ACP can be beneficial for residents' relatives, as it may ease their decision making. Whereas relatives' wellbeing and confidence in their role as surrogate decision maker may be important outcomes of ACP, the patient's values and preferences should be central.
The future of ACP
We distinguish a number of steps in moving ACP forward. First, we need a broader base of evidence from methodologically sound studies such as randomized controlled trials (RCTs), demonstrating the extent of effectiveness of different models of ACP. Whereas previous studies have shown beneficial effects, ACP is a complex intervention and we lack insight into which elements exactly bring these beneficial effects about and what their potential drawbacks are. Potentially effective elements of ACP are patients' raised awareness that they have options to choose from; having a targeted and structured conversation about preferences for future or current care; the documentation of such preferences; the mere fact that patients, relatives, and care professionals communicate, or the patients' knowledge that their relatives know their preferences and will act on their behalf. We recommend further research to disentangle these potentially effective elements of ACP, but also their potentially negative impact, and to explore whether ACP models can be tailored to preferences of patients from different cultures or backgrounds, such as those with low literacy levels. We also need to understand who is best equipped to initiate and guide the process of ACP and how that should be done, what the right moment to start ACP is, what can be appropriate settings for ACP, and how the ACP process should be supported over time when a patient's condition deteriorates. Finally, guidance for professionals is needed on how to implement evidencebased ACP models in their practice. Raising healthcare professionals' awareness and educating them about the importance of timely communication with patients and their relatives about what really matters to them should be part of healthcare professional training programs at any level.
